| Literature DB >> 35868665 |
Matteo Tosato1, Francesca Ciciarello2, Maria Beatrice Zazzara2, Delfina Janiri2, Cristina Pais2, Stefano Cacciatore2, Rossella Montenero2, Maria Sandrina Leone2, Enea Chisci2, Anna Picca2, Vincenzo Galluzzo2, Hélio José Coelho-Junior3, Riccardo Calvani2, Emanuele Marzetti4, Francesco Landi4.
Abstract
COVID-19 pandemic forced countries to adopt strategies aimed at responding to the health emergency by containing contagion. Lockdowns have ensured the achievement of this goal but imposed substantial restrictions to the freedom of movement and resulted in social isolation for a large share of vulnerable people. The aim of the present study was to evaluate the impact of COVID-19 pandemic and associated emergency restriction measures on the quality of life, lifestyle habits, and psychosocial status in older adults.Entities:
Keywords: COVID-19; Frailty; Mobility disorders; Older adults; Quality of life
Mesh:
Year: 2022 PMID: 35868665 PMCID: PMC9080082 DOI: 10.1016/j.cger.2022.05.002
Source DB: PubMed Journal: Clin Geriatr Med ISSN: 0749-0690 Impact factor: 3.529
General and clinical characteristics of study population according to lifestyle change during COVID-19 pandemic era
| Characteristics | Total Sample (n = 504) | Lifestyle Change | ||
|---|---|---|---|---|
| NO (n = 220) | YES (n = 284) | |||
| Age (y) | 83.2 ± 5.1 | 83.8 ± 4.5 | 82.8 ± 5.5 | |
| Gender | ||||
| Male | 221 (44) | 104 (47) | 117 (41) | 0.10 |
| Female | 283 (56) | 116 (53) | 167 (59) | |
| Education (y) | 11.4 ± 5.3 | 10.7 ± 6.0 | 11.8 ± 4.7 | |
| Hypertension | 276 (55) | 117 (53) | 159 (56) | 0.28 |
| Ischemic heart disease | 55 (11) | 26 (12) | 29 (10) | 0.34 |
| Arrhythmia | 80 (16) | 32 (15) | 48 (17) | 0.27 |
| Diabetes | 75 (15) | 36 (16) | 39 (14) | 0.24 |
| Renal failure | 14 (3) | 6 (3) | 8 (3) | 0.58 |
| COPD | 33 (7) | 18 (8) | 15 (5) | 0.13 |
| Cancer | 49 (10) | 17 (8) | 32 (11) | 0.11 |
| Osteoarthritis | 41 (8) | 18 (8) | 23 (8) | 0.55 |
| Number of diseases | 2.1 ± 1.4 | 2.3 ± 1.5 | 2.1 ± 1.2 | 0.12 |
| Number of drugs | 3.6 ± 2.8 | 3.8 ± 2.9 | 3.5 ± 2.6 | 0.20 |
| Flu vaccination | 427 (85) | 189 (86) | 238 (84) | 0.30 |
| Pneumococcal vaccination | 183 (36) | 78 (36) | 105 (37) | 0.39 |
| Routine blood check | 397 (78) | 166 (76) | 231 (81) | 0.07 |
| General practitioner visit | 321 (64) | 131 (60) | 190 (67) | 0.05 |
| Clinical frailty scale | 3.5 ± 1.3 | 3.7 ± 1.3 | 3.3 ± 1.3 | |
Data are given as number (percent) for gender, diseases, flu and pneumococcal vaccination, blood check, and general practitioner visit; for all the other variables, means ± SD are reported.
Quality of life and psychological well-being of study population according to lifestyle change during COVID-19 pandemic era∗
| Characteristics | Total Sample (n = 504) | Lifestyle Change | ||
|---|---|---|---|---|
| NO (n = 220) | YES (n = 284) | |||
| Self-rated health (visual analogue scale) | ||||
| VAS pre-COVID-19 | 76.5 ± 16.9 | 75.8 ± 18.3 | 77.0 ± 15.8 | 0.42 |
| VAS COVID-19 era | 69.6 ± 19.2 | 70.7 ± 19.8 | 68.7 ± 18.8 | 0.25 |
| Worsened EQ-VAS | 217 (43) | 75 (35) | 142 (65) | |
| WHO-5: The 5-item World Health Organization Well-Being Index | ||||
| WHO-5 | 15.8 ± 5.2 | 16.3 ± 5.4 | 15.4 ± 5.0 | 0.07 |
| WHO-5 ≤15 | 229 (45) | 87 (39) | 142 (50) | |
| K10 test—Kessler Psychological Distress Scale | ||||
| K10 test | 16.0 ± 4.8 | 15.7 ± 4.9 | 16.2 ± 4.8 | 0.23 |
| K10 test more than 19 | 116 (23) | 46 (21) | 70 (25) | 0.19 |
Worsened quality of life: greater than 5 points lost at VAS.
WHO-5: The World Health Organisation—Five Well-Being Index (ranging from 0 to 25, with 0 representing the worst imaginable well-being and 25 representing the best imaginable well-being).
K10 test: Kessler Psychological Distress Scale (ranging from 0 to 50, with 0 representing the better result and 50 representing the worsen result).
Multivariate logistic regression (NO lifestyle change vs YES lifestyle change)
| OR [95% CI] | Wald | p | |
|---|---|---|---|
| Gender | 1.27 [0.87–1.86] | 1.59 | 0.20 |
| Age | 0.98 [0.94–1.02] | 0.90 | 0.34 |
| Education | 1.03 [0.99–1.06] | 3.14 | 0.07 |
| Heart failure | 0.45 [0.20–1.05] | 3.35 | 0.06 |
| Clinical frailty scale | 0.78 [0.67–0.91] | 10.15 | |
| Worsened EQ-VAS | 2.03 [1.38–3.00] | 12.89 | |
| WHO-5 ≤15 | 1.46 [0.98–2.16] | 3.56 | 0.06 |
Significant results in bold.
Abbreviations: CI, confidence interval; OR, odds ratio; p, statistical significance.
Fig. 1Usual activities interrupted during pandemic.
Fig. 2Self-report difficulty in mobility before and during COVID-19 pandemic.
Fig. 3Self-report depression status before and during COVID-19 pandemic.